FORT Robotics Gets $20 Million in Investor Commitments
Oct 22, 2026
Funding
Trinity Capital Invests $45 Million in Rapid Micro Biosystems
Sep 22, 2025
Trinity Capital has committed $45 million in growth capital to Rapid Micro Biosystems to support its automation solutions in healthcare manufacturing.
Trinity Capital Inc. has committed $45 million in growth capital to Rapid Micro Biosystems, announced in a press release. Rapid Micro Biosystems specializes in automating microbial quality control processes, which are crucial for the efficient manufacturing and safe release of healthcare products.
The investment will aid in scaling Rapid Micro's operations, including the global expansion of its Growth Direct platform. This platform automates microbial quality control testing, providing faster and more accurate results, thereby enhancing operational efficiency and data integrity. The funding will also support efforts to reduce product costs and improve manufacturing efficiencies.
Robert Spignesi, President and CEO of Rapid Micro Biosystems, expressed satisfaction with the partnership, highlighting the shared vision of automating manual testing methods in biopharma manufacturing. This financial boost is expected to strengthen Rapid Micro's market position and support its long-term growth objectives.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareMore from Funding
Nov 13 Polar DC adds Palistar financing as 2026 commitments pass EUR 1 billion Nov 13 Peter Sarlin's PostScriptum takes majority stake in Finnish AI deployment firm Brillian Nov 13 MISTT raises £5 million to build a space-and-time data layer for AI and autonomous systems Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 12 Inveniam acquires Docugami, the document AI startup of XML pioneer Jean PaoliFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Tractian Raises $130 Million at $1.4 Billion Valuation
Oct 22, 2026
Funding
XRlabs Raises €7.48 Million for Surgical AI
Oct 20, 2026
Funding
Reliable Robotics Adds $115 Million to Series D
Oct 20, 2026
Funding
Biomatter Raises $18 Million for AI Enzyme Design
Nov 12, 2026
Funding
Formation Bio Forms $600 Million Drug Development Fund
Oct 28, 2026
Funding
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.